IP Library Granted Patent US 8,469,936
Granted Patent B2
US 8,469,936 · App. 12/823,958 · Granted Jun 25, 2013

Reduced-pressure dressings, systems, and methods employing desolidifying barrier layers

Inventors: Timothy Mark Robinson (Basingstoke, GB); Christopher Brian Locke (Bournemouth, GB)
Assignee: KCI Licensing, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,469,936
App. No.
12/823,958
Granted
Jun 25, 2013
Kind
B2
Abstract

Reduced-pressure medical dressings, systems, and methods involve a dressing with a first barrier layer that desolidifies when exposed to a fluid—typically a liquid—to form a treatment aperture in the first barrier that is used to deliver reduced pressure to a tissue site. The first barrier layer is formed from a desolidifying material. The system includes a drape covering a second surface of a manifold and a portion of the patient's epidermis to provide a substantially sealed space containing a manifold and the first barrier layer. Other systems, dressings, and methods are also disclosed.

Claims (41)

1. A system for providing reduced-pressure therapy to a tissue site of a patient, the system comprising:

a reduced-pressure source for supplying reduced pressure;

a manifold having a first, inward-facing surface and a second surface, the manifold operable to transfer the reduced pressure;

a first barrier layer covering at least a portion of the first, inward-facing surface of the manifold, the first barrier layer comprising a first portion and a second portion formed from a desolidifying material; and

a drape for covering the second surface of the manifold and a portion of the patient's epidermis to provide a substantially sealed space containing the manifold and the first barrier layer;

wherein the first portion is adapted to desolidify and form a treatment aperature under reduced pressure, while the second portion is adapted to separate the manifold from epidermis adjacent to the tissue site and remain intact under reduced pressure.

2. The system of claim 1 , further comprising:

a second barrier layer covering the second surface of the manifold, the second barrier layer operable to desolidify in the presence of fluid to expose the manifold.

3. The system of claim 1 , further comprising:

a second barrier layer covering the second surface of the manifold, the second barrier layer operable to desolidify in the presence of fluid to expose the manifold to the tissue site, wherein the second barrier layer desolidifies at a faster rate than the first barrier layer when in the presence of the fluid.

4. The system of claim 1 , wherein the first barrier layer is formed with a plurality of perforations for providing fluid communication across the first barrier layer.

5. The system of claim 1 , wherein the first barrier layer comprises a first plurality of perforations for providing fluid communication across the first barrier layer, and further comprising:

a second barrier layer on the second surface of the manifold, the second barrier layer comprising a second plurality of perforations for providing fluid communication across the second barrier layer.

6. The system of claim 1 , wherein the first barrier layer comprises a first plurality of perforations for providing a flow rate (X) across the first barrier layer, and further comprising:

a second barrier layer on the second surface of the manifold, the second barrier layer comprising a second plurality of perforations for providing a flow rate (Y) across the second barrier layer, wherein Y is greater than X.

7. The system of claim 1 , wherein the first portion of the first barrier layer is operable to desolidify into a liquid when contacting a fluid.

8. The system of claim 1 , wherein the desolidifying material becomes substantially fluid permeable in the presence of a liquid.

9. An apparatus for providing reduced-pressure therapy to a tissue site of a patient, the apparatus comprising:

a manifold having a first, inward-facing surface and a second surface, the manifold operable to transfer reduced pressure; and

a first barrier layer covering at least a portion of the first, inward-facing surface of the manifold, the first barrier layer comprising a first portion and a second portion formed from a desolidifying material;

wherein the first portion is adapted to desolidify and form a treatment aperature under reduced pressure, while the second portion is adapted to separate the manifold from epidermis adjacent to the tissue site and remain intact under reduced pressure.

10. The apparatus of claim 9 , further comprising:

a second barrier layer covering the second surface of the manifold, the second barrier layer operable to desolidify in the presence of a fluid to expose the manifold to the tissue site.

11. The apparatus of claim 9 , further comprising:

a second barrier layer covering the second surface of the manifold, the second barrier layer operable to desolidify in the presence of a fluid to expose the manifold to the tissue site, and wherein the second barrier layer desolidifies at a faster rate than the first barrier layer when in the presence of the fluid.

12. The apparatus of claim 9 , wherein the first barrier layer comprises a plurality of perforations providing fluid communication across the first barrier layer.

13. The apparatus of claim 9 , wherein the first barrier layer comprises a first plurality, of perforations for providing fluid communication across the first barrier layer, and further comprising:

a second barrier layer on the second surface of the manifold, the second barrier layer comprising a second plurality of perforations for providing fluid communication across the second barrier layer.

14. The apparatus of claim 9 , wherein the first barrier layer comprises a first plurality of perforations for providing a flow rate (X) across the first barrier layer, and further comprising:

a second barrier layer on the second surface of the manifold, the second barrier layer comprising a second plurality of perforations for providing a flow rate (Y) across the second barrier layer, wherein Y is greater than X.

15. The apparatus of claim 9 , wherein the first barrier layer is operable to desolidify into a liquid when contacting the fluid.

16. The apparatus of claim 9 , wherein the first barrier layer includes a healing agent, and wherein the healing agent is released as the first barrier layer desolidifies.

17. A method for providing reduced-pressure therapy to a tissue site of a patient, the method comprising:

applying a first portion and a second portion of a barrier layer over the tissue site, wherein the second portion is applied to epidermis adjacent to the tissue site;

applying a manifold over the barrier layer such that the second portion of the barrier layer is disposed between the manifold and the epidermis;

desolidifying the first portion to create a treatment aperture while the second portion remains intact; and

applying a reduced pressure to the tissue site via the treatment aperture.

18. The method of claim 17 , wherein applying the reduced pressure to the tissue site includes drawing a desolidified portion of the barrier layer material out of the dressing via the manifold.

19. The method of claim 17 , further comprising:

applying a fluid to the dressing from a fluid source to facilitate the desolidification of the barrier layer.

20. The method of claim 17 , further comprising covering the manifold and the barrier layer with a drape to provide a substantially sealed space containing the manifold and the barrier layer.

Assignments (4)
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
Continuity (2)
Provisional Application 61225604 · Jul 15, 2009
Related Publication 20110015595A1 · Jan 20, 2011